Skip to main content
Premium Trial:

Request an Annual Quote

Celera Makes Stem Cell Deal, Acquires Paracel, Reaches Mouse Milestone

Premium

ROCKVILLE, Md.--Celera is expected to announce at any moment that it has completed the human genome sequence. Instead, so far this month, it has announced a string of other achievements.

 

On June 1, Celera said that it had sequenced more than one billion base pairs of the mouse genome, which it began sequencing on April 6. The mouse sequence data is expected to be used in a human genome annotation jamboree that Celera will reportedly host in June or July.

 

Celera also announced that it established a deal with Geron, a company with expertise in human pluripotent stem cell biology, by which it will identify and determine the function of genes important in early human development. Celera will use data derived from the collaboration to enhance annotation of the human genome and develop and commercialize probe sets for gene expression analysis. Geron will develop and commercialize small molecule drugs and other products.

 

Celera also said it had closed its acquisition of Paracel, a genomic and text analysis supercomputing technology company. All equity of Paracel was exchanged for approximately 2.26 million shares of Celera stock.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.